Thromboxane synthetase enzyme inhibiting N-[(1_H-imidazol-1-yl) and (1_H-1,2,4-triazol-1-yl)alkyl]pyridinecarboxamides

摘要

This invention concerns novel N-[(1_H-imidazol-1-yl) and (1_H-1,2,4-triazol-1-yl)alkyl]pyridinecarboxamides which are useful as inhibitors of thromboxane synthetase and/or as hypotensive agents in the treatment of hypertension and myocardial ischemia.